Literature DB >> 1661313

Antiidiotypic vaccination against murine coronavirus infection.

A Lamarre1, J Lecomte, P J Talbot.   

Abstract

Rabbit polyclonal antiidiotypic antibodies were generated against a neutralizing mAb specific for a conformational epitope on the S glycoprotein of murine hepatitis virus, strain A59 (MHV-A59). These anti-Id were directed predominantly against an Id that was undetectable in rabbit and rat anti-MHV-A59 sera and weakly represented in syngeneic and allogeneic antiviral sera. However, some partial idiotypic sharing was observed between the Id-bearing antibody and a mAb with a similar antigenic site specificity. The anti-Id inhibited the virus-binding and neutralizing activities of the immunizing antibody, demonstrating that they recognize paratope-associated idiotopes. Mice immunized with affinity-purified anti-Id developed MHV-A59-specific antibodies that neutralized viral infectivity to high titers. Moreover, these animals survived an otherwise lethal challenge with viral murine hepatitis virus, unlike control mice immunized with normal rabbit Ig. These results indicate that at least a subpopulation of the polyclonal anti-Id could induce a protective immune response directed toward a biologically important MHV-A59 epitope, and demonstrate the feasibility of antiidiotypic vaccination against a coronavirus infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661313

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B complex of human cytomegalovirus.

Authors:  E S Tackaberry; J Hamel; Y Larose; B R Brodeur
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

2.  Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.

Authors:  C Daniel; R Anderson; M J Buchmeier; J O Fleming; W J Spaan; H Wege; P J Talbot
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis.

Authors:  A F Kolb; L Pewe; J Webster; S Perlman; C B Whitelaw; S G Siddell
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus 70 conformational epitopes.

Authors:  J A Wiley; J Hamel; B R Brodeur
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.

Authors:  L Brossay; A Villeneuve; G Paradis; L Coté; W Mourad; J Hébert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 6.  Moloney leukemia virus-induced cell surface antigen mimicry by monoclonal antibodies.

Authors:  J G Baskin; T J Powell; R V Srinivas; M Elliott; E W Lamon
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  Genetic control of anti-idiotypic vaccination against coronavirus infection.

Authors:  M W Yu; S Lemieux; P J Talbot
Journal:  Eur J Immunol       Date:  1996-12       Impact factor: 5.532

8.  A recombinant single chain antibody neutralizes coronavirus infectivity but only slightly delays lethal infection of mice.

Authors:  A Lamarre; M W Yu; F Chagnon; P J Talbot
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

9.  Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.

Authors:  Zhaochun Chen; Mahtab Moayeri; Yi-Hua Zhou; Stephen Leppla; Suzanne Emerson; Andrew Sebrell; Fujuan Yu; Juraj Svitel; Peter Schuck; Marisa St Claire; Robert Purcell
Journal:  J Infect Dis       Date:  2006-02-02       Impact factor: 5.226

10.  Identification of a 37 kDa plant protein that interacts with the turnip mosaic potyvirus capsid protein using anti-idiotypic-antibodies.

Authors:  K McClintock; A Lamarre; V Parsons; J F Laliberté; M G Fortin
Journal:  Plant Mol Biol       Date:  1998-05       Impact factor: 4.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.